# Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

> **NCT04411836** · PHASE3 · COMPLETED · sponsor: **Menzies School of Health Research** · enrollment: 960 (actual)

## Conditions studied

- Vivax Malaria
- Plasmodium Vivax
- Malaria, Vivax
- Malaria Relapse

## Interventions

- **DRUG:** Tafenoquine
- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT04411836
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-25
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 960 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04411836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04411836, "Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04411836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*